WHO Bans Ivermectin Use For COVID-19 Patients, FLCCC: Proven No Side Effects

Illustration (Pixabay)

JAKARTA - The World Health Organization (WHO) has not given permission to use ivermectin to COVID-19 patients. The Front Line Covid Critical Care or FLCCC Alliance considers this recommendation to be inappropriate, because ivermectin is considered to be able to inhibit the handling of COVID-19. Even if taken every day for treatment and every week for prevention. Ivermectin is an anthelmintic. While generally deworming drugs are used once a year, and in some cases a person must take it at least every 6 months. "High doses have also been proven to have no side effects. This (ivermectin) is even included in the safest drugs in the pharmaceutical industry. ," he said in a virtual discussion, June 28.

According to FLCCC data, the use of ivermectin for COVID-19 patients has been carried out by 33 countries. These include Brazil, Zimbabwe, Japan, and India. In fact, 15 countries have managed to overcome COVID-19 cases in their countries. On the same occasion, the General Chair of the Indonesian Farmers' Association (HKTI) Moeldoko admitted that he had distributed the drug ivermectin to a number of areas. He also claimed that ivermectin was effective in treating COVID-19 patients, including Depok to East Semarang. The efficacy of almost all areas is close to 100 percent to reduce COVID-19," he said in a virtual discussion, Monday, June 28. Furthermore, Moeldoko also claimed that ivermectin, known as an anthelmintic, was also able to reduce COVID-19 cases in East Semarang, Sragen, until Kudus. "Seeing this temporary data, we are quite optimistic that ivermectin can be an effective drug solution to cure COVID-19 patients," he said. In addition, Moeldoko revealed the reason he distributed ivermectin. According to him, this is due to the condition of the spread of COVID-19 which is currently increasingly widespread and continues to increase. Because of that, he dared to share ivermectin as one of the alternatives with effective evidence. Furthermore, Moeldoko said that in the current critical condition, he cannot just stand still. Moreover, he said, COVID-19 vaccination has not been evenly distributed throughout Indonesia. "In facing this critical situation, should we be silent? I don't think so. We must do something, silence is a risk of death. Doing something is not necessarily death. A choice. So far, the WHO has only recommended the use of ivermectin for clinical trials, not for COVID-19 patients, regardless of severity. WHO also has not yet recommended any drugs that have been shown to be effective in the treatment of COVID-19 patients.